GB2470358A - Hyperbaric dressing - Google Patents
Hyperbaric dressing Download PDFInfo
- Publication number
- GB2470358A GB2470358A GB0908507A GB0908507A GB2470358A GB 2470358 A GB2470358 A GB 2470358A GB 0908507 A GB0908507 A GB 0908507A GB 0908507 A GB0908507 A GB 0908507A GB 2470358 A GB2470358 A GB 2470358A
- Authority
- GB
- United Kingdom
- Prior art keywords
- dressing
- layer
- absorbent layer
- fluid
- enclosing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000002250 absorbent Substances 0.000 claims abstract description 105
- 230000002745 absorbent Effects 0.000 claims abstract description 105
- 239000012530 fluid Substances 0.000 claims abstract description 62
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims abstract description 29
- 239000001301 oxygen Substances 0.000 claims abstract description 29
- 229910052760 oxygen Inorganic materials 0.000 claims abstract description 29
- 239000000853 adhesive Substances 0.000 claims description 19
- 230000001070 adhesive effect Effects 0.000 claims description 19
- 238000000034 method Methods 0.000 claims description 16
- 239000000463 material Substances 0.000 claims description 12
- 239000006260 foam Substances 0.000 claims description 9
- 230000035876 healing Effects 0.000 claims description 9
- 238000004519 manufacturing process Methods 0.000 claims description 8
- 238000010521 absorption reaction Methods 0.000 claims description 5
- 239000007789 gas Substances 0.000 claims description 3
- 239000010410 layer Substances 0.000 description 131
- 206010052428 Wound Diseases 0.000 description 61
- 208000027418 Wounds and injury Diseases 0.000 description 61
- 210000001519 tissue Anatomy 0.000 description 30
- 210000000416 exudates and transudate Anatomy 0.000 description 17
- 230000002093 peripheral effect Effects 0.000 description 3
- 239000004814 polyurethane Substances 0.000 description 3
- 229920002635 polyurethane Polymers 0.000 description 3
- 208000005189 Embolism Diseases 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000005587 bubbling Effects 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 239000006261 foam material Substances 0.000 description 2
- 238000005469 granulation Methods 0.000 description 2
- 230000003179 granulation Effects 0.000 description 2
- 238000002803 maceration Methods 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- 206010007710 Cartilage injury Diseases 0.000 description 1
- 206010011985 Decubitus ulcer Diseases 0.000 description 1
- 208000008960 Diabetic foot Diseases 0.000 description 1
- 208000005230 Leg Ulcer Diseases 0.000 description 1
- 206010028885 Necrotising fasciitis Diseases 0.000 description 1
- 208000004210 Pressure Ulcer Diseases 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 238000005299 abrasion Methods 0.000 description 1
- 239000012790 adhesive layer Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 210000003722 extracellular fluid Anatomy 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 239000013003 healing agent Substances 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 210000003041 ligament Anatomy 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 239000011505 plaster Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 208000009954 pyoderma gangrenosum Diseases 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000037390 scarring Effects 0.000 description 1
- 238000007493 shaping process Methods 0.000 description 1
- 239000002344 surface layer Substances 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 230000000451 tissue damage Effects 0.000 description 1
- 231100000827 tissue damage Toxicity 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/02—Adhesive plasters or dressings
- A61F13/0203—Adhesive plasters or dressings having a fluid handling member
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/02—Adhesive plasters or dressings
- A61F13/023—Adhesive plasters or dressings wound covering film layers without a fluid handling layer
-
- A61F13/05—
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/90—Negative pressure wound therapy devices, i.e. devices for applying suction to a wound to promote healing, e.g. including a vacuum dressing
- A61M1/91—Suction aspects of the dressing
- A61M1/915—Constructional details of the pressure distribution manifold
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M35/00—Devices for applying media, e.g. remedies, on the human body
- A61M35/30—Gas therapy for therapeutic treatment of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00089—Wound bandages
- A61F2013/0017—Wound bandages possibility of applying fluid
- A61F2013/00174—Wound bandages possibility of applying fluid possibility of applying pressure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00089—Wound bandages
- A61F2013/00246—Wound bandages in a special way pervious to air or vapours
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00361—Plasters
- A61F2013/00846—Plasters with transparent or translucent part
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00361—Plasters
- A61F2013/00855—Plasters pervious to air or vapours
- A61F2013/00872—Plasters pervious to air or vapours with controlled oxygen permeability
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/15—Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators
- A61F13/53—Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators characterised by the absorbing medium
- A61F2013/530802—Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators characterised by the absorbing medium characterized by the foam or sponge other than superabsorbent
- A61F2013/53081—Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators characterised by the absorbing medium characterized by the foam or sponge other than superabsorbent with special pore dimension or arrangement
- A61F2013/530817—Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators characterised by the absorbing medium characterized by the foam or sponge other than superabsorbent with special pore dimension or arrangement being open cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/90—Negative pressure wound therapy devices, i.e. devices for applying suction to a wound to promote healing, e.g. including a vacuum dressing
- A61M1/94—Negative pressure wound therapy devices, i.e. devices for applying suction to a wound to promote healing, e.g. including a vacuum dressing with gas supply means
Abstract
A hyperbaric dressing comprising: an enclosing layer 4 impermeable to a first fluid, for forming an enclosure around damaged tissue, an absorbent layer 6 contactable with the damaged tissue, absorbent to a first fluid and arranged such that in use it is situated within the enclosure, and a fluid conduit 8 for delivery of a second fluid to the enclosure, in which the fluid conduit 8 is arranged such that it extends into the enclosure and is spaced from the damaged tissue. The dressing may include an opening 12 in the absorbent layer 6 in which the end of the fluid conduit 8 is positioned. The conduit 8 can be used to supply oxygen to the wound.
Description
HYPERBARIC DRESSING AND METHOD
This present invention relates to a hyperbaric dressing and methods for using and manufacturing a hyperbaric dressing.
BACKGROUND OF THE INVENTION
It is known that a supply of oxygen to a wound or through the skin covering a wound can be used to promote healing and to reduce scarring of damaged tissue. Typically, oxygen is absorbed by tissue fluids, thus improving the io oxygen content of intercellular fluids and/or promoting metabolism and repair of the damaged tissue.
As such, there are numerous ailments which may benefit from the topical application of oxygen to damaged tissue, for example, osteomylelitis, tendon, IS ligament and cartilage damage, fractures, burns, scalds, necrotising fasciitis, such as pyoderma gangrenosum, pressure-induced decubitus (bed sores), venous and diabetic foot and leg ulcers, as well as cuts, abrasions and surgically-induced wounds and incisions.
In the healing process of non-infected wounds, low levels of exudate moisturising the skin surrounding a wound may be considered positive. When exudate becomes excessive or the wound becomes chronic' and non-healing or when infection becomes established, exudate may take on a different guise and has justifiably been termed a wounding agent in its own right' as it has the capacity to degrade growth factors. Excessive and particularly infected exudate from non-healing wounds may cause maceration to intact skin inhibiting the healing process. Mild maceration can be seen in the puffy whiteness to skin surrounding a wound when a sticking plaster' is removed.
Highly absorbent, non-hyperbaric dressings are known in the art such as island dressings' which contain absorbent foam material for contact with the wound, allowing exudate to be wicked away into the foam material. In such a dressing, a foam island may be fixed to a central portion of a liquid-impermeable enclosing layer. A peripheral portion of the enclosing layer encircling the foam is adhesive, so that when the foam is positioned over a wound, the adhesive layer sticks to the patient's skin and forms a seal around the wound to prevent exudate escaping the dressing. Soiled or leaking dressings are seen as poor nursing practice and are distressing to patients.
A known attempt to combine the benefits of an absorbent dressing and a hyperbaric dressing requires a tube for delivering oxygen to be placed in the wound under a conventional absorbent material which is then overlaid with an occlusive (sealed) dressing. However, placing a tube in a wound is undesirable and problematic as the presence of the tube can be uncomfortable for the io patient and physically disturb the wound, and because removal of the tube after treatment disturbs the granulation of new tissue. Furthermore, oxygen discharged directly into wound tissue raises the concern of oxygen embolism.
Consequently, there is a desire to provide a hyperbaric wound dressing which allows absorption of exudate whilst also allowing delivery of oxygen, without the means for delivering the oxygen adversely affecting the wound itself.
SUMMARY OF INVENTION
The invention relates to a hyperbaric dressing, a method of treatment for assisting the healing of damaged tissue and a method of manufacturing a hyperbaric dressing, as defined in the appended independent claims to which reference should now be made. Advantageous or preferred features are set forth in the dependent claims.
* 25 A hyperbaric dressing according to the present invention may advantageously comprise: an enclosing layer impermeable to a first fluid, such as wound exudate, for forming an enclosure around damaged tissue; an absorbent layer contactable with the damaged tissue, absorbent to the first fluid and arranged such that in use it is situated within the enclosure; and a fluid conduit for delivery of a second fluid, such as oxygen, to the enclosure. The fluid conduit is advantageously arranged such that it extends into the enclosure and is spaced from the damaged tissue. Spacing the fluid conduit from damaged tissue, such as a wound, may advantageously ensure that problems associated with the prior art method of placing an oxygen-delivery conduit or tube in, or in contact with damaged tissue are avoided.
Preferably, a cavity may be defined within the absorbent layer, in which the fluid conduit is received. The cavity may be created by shaping the absorbent layer during manufacture or by cutting through the thickness of the absorbent layer.
Alternatively, the cavity may be created by cutting to a pre-determined depth into the absorbent layer such that a step or depression is formed in a surface of the absorbent layer. Another form of cavity may comprise a tunnel which is completely enclosed on all sides by absorbent layer material.
io In a preferred embodiment, the fluid conduit is held away from the damaged tissue by a portion of the absorbent layer. This could be achieved by positioning the fluid conduit such that it is sandwiched between the enclosing layer and the absorbent layer, thus being separated from the damaged tissue by the entire thickness of the absorbent layer. But this structure has the potential I5 disadvantage that the presence of the conduit behind a part of the absorbent layer when the dressing is applied to a wound would make the surface of the absorbent layer in contact with the wound uneven. This may irritate the wound or cause discomfort to the patient, although this structure is an improvement on the prior art structure in which the conduit is placed directly into or in contact with the wound. If the absorbent layer is sufficiently thick and the conduit sufficiently small this structure may be acceptable. Alternatively, the absorbent layer may comprise a cavity shaped to receive or fit over or around the conduit within the dressing, as described above. In this case the thickness of the absorbent layer should be greater than the diameter of the conduit.
If the cavity does not extend through the entire thickness of the absorbent layer but is formed to a pre-determined depth into the absorbent layer, the conduit may be housed within the cavity such that it is separated from the damaged tissue by the remaining thickness of the absorbent layer beneath the cavity.
In a further alternative, the cavity is formed through the entire thickness of the absorbent layer and the conduit is secured within the cavity, spaced from the surface of the absorbent layer that will contact the wound. In a preferred embodiment this may be achieved by securing the conduit to the enclosing layer, at the base of the cavity.
In a preferred embodiment, the enclosing layer may comprise an adhesive surface. The enclosing layer extends beyond the periphery of the absorbent layer and the adhesive surface of this peripheral region of the enclosing layer s may allow the enclosing layer to adhere to the surface around the damaged tissue and so to create the enclosure or headspace around the wound. The adhesion to the surface around the damaged tissue may create a seal against the outhow of wound exudate from the dressing. The creation of a seal may also allow a fluid such as oxygen, supplied through the fluid conduit, to to accumulate in the headspace above the wound. The adhesive surface around the periphery of the enclosing layer may be exposable by the removal of a cover layer positioned over the adhesive surface in known manner.
Preferably, the adhesive surface extends over the entire surface of one side of the enclosing layer. The adhesive surface may then be used, preferably during manufacture of the dressing, to secure the fluid conduit and the absorbent layer to the enclosing layer. Thus, the fluid conduit may be secured by adhesion to the enclosing layer, such that an open end of the conduit is at a predetermined position, for example at a central point of the dressing. The conduit may then extend away from the predetermined position and across an edge of the enclosing layer. The absorbent layer may then be secured by adhesion to the enclosing layer, such that the cavity defined in the absorbent layer aligns with or fits over the conduit. The area of the enclosing layer is preferably greater than the area of the surface of the absorbent layer which contacts the wound, so that the absorbent layer forms an island surrounded by a peripheral region of the enclosing layer which may adhere to the skin surrounding the wound.
When the dressing is in place over a wound, the conduit may extend from an edge of the dressing to permit delivery of the second fluid, such as oxygen, to the enclosure or headspace formed by the dressing over the wound.
In a further preferred embodiment, an opening or window is defined through the thickness of the absorbent layer, and the enclosing layer is transparent or translucent or comprises a transparent or translucent window portion aligned with the opening. Advantageously, such an opening may allow the wound to be observed without removal of the dressing. In addition, if the opening fills with exudate, the delivery of the second fluid, such as oxygen to the wound may be observed through the production of bubbles within the enclosure around the damaged tissue. Preferably, the opening is located in a substantially central position of the dressing. However, there may be a plurality of openings through the absorbent layer. The cross-section of the opening(s) may be any shape including circular, square or star-shaped.
If the dressing comprises an opening through the absorbent layer, it is io preferable for an end of the conduit to be positioned at the opening. This would allow for the clear passage of fluid from the fluid conduit to the wound surface and visual effects resulting from fluid delivery, such as bubbling, may be more readily observed. For this purpose, the opening and the cavity (if present) in the absorbent layer are preferably continuous or contiguous.
In a preferred embodiment, the enclosing layer may be gas-permeable. This would enable the damaged tissue and the surface surrounding the damaged tissue, for example the skin, to breathe. It is particularly advantageous for a portion of the enclosing layer which may adhere to the skin or other tissue to be gas-permeable, in known manner. The enclosing layer may comprise polyurethane or any other plastics material.
Although the enclosing layer is preferably gas-permeable, it is also advantageous that its permeability should be sufficiently low to enable a hyperbaric pressure to be generated within the enclosure beneath the dressing by the second fluid supplied through the conduit. Thus, the rate of supply of the second fluid, the desired hyperbaric pressure and the area of the dressing should be taken into account in selecting the gas-permeability of the enclosing layer.
The first fluid preferably comprises exudate or any fluid released by damaged tissue and it may comprise transudate. To aid in absorption of such fluids, the absorbent layer preferably comprises an open-cell material, such as foam, making it suitable for direct wound surface contact. It may comprise a surface layer designed for wound contact. The absorbent material is preferably able to wick away excess fluid from the site of tissue damage whilst allowing maintenance of low levels of exudate to enable wound healing. Preferably, the enclosing layer does not allow the first fluid to exit the enclosure when in use, but it could comprise a means for allowing excess amounts of first fluid out, such as a perforation, for example for absorbtion bya sepal-te dressing material.
The absorbent layer may comprise material which is permeable to both the first and second fluid. A gas-permeable absorbent layer may allow more efficient delivery of the second fluid to the damaged tissue by allowing diffusion or flow through the absorbent layer. An open-cell foam is suitable for this In a preferred embodiment, the absorbent layer may comprise material with an absorption capacity greater than or equal to 0.1, 0.2, 0.3, 0.4, 0.5 or 0.6 mI/cm2.
is The second fluid preferably comprises oxygen to aid in the healing of tissue.
Alternatively or additionally, the first fluid may comprise other beneficial reagents such as cosmetic, anti-microbial agents, healing agents and pain-reducing agents, which may be administered constantly or periodically. In a preferred embodiment, the fluid comprising oxygen is deliverable at a rate of 5 to 25, 10 to 20 or most preferably 12 to 15 mI/hour. This is especially advantageous if the enclosing layer is breathable, such as if it comprises polyurethane. Oxygen delivery at such a rate may be sufficient to overcome the breathability of the enclosing layer to maintain a suitable pressure in the enclosure or the headspace above the damaged tissue. A suitable pressure may be approximately 35 mm Hg (4.67 kPa), although this may vary depending on the size and nature of the wound and the corresponding size of the dressing.
A method of treating a human or animal to assist in the healing of damaged tissue, according to the invention, may advantageously comprise the steps of: applying a hyperbaric dressing as described above to the damaged tissue; and supplying the dressing with the second fluid.
A method for manufacturing a hyperbaric dressing according to the present invention may comprise the steps of: cutting or forming a cavity into an absorbent layer, absorbent to a first fluid; attaching a first surface of the absorbent layer to an enclosing layer; and inserting a portion of a fluid conduit, capable of delivering a second fluid, into the cavity such that it is spaced beneath a second surface of the absorbent layer distant from the enclosing layer. The steps of this method are not necessarily required to be carried out in this order. For example the conduit may be attached to the enclosing layer before or after or at the same time as the absorbent layer.
In a preferred embodiment, the method may further comprise cutting an opening or window through the absorbent layer. The opening may be cut such that it is continuous or contiguous with the cavity.
Preferably, the enclosing layer is attached to the absorbent layer by adhesion, Advantageously, the fluid conduit is attached to the enclosing layer by adhesion.
In an alternative aspect of the invention, the dressing may be fabricated by attaching the conduit to the absorbent layer, for example within a cavity formed or cut in the absorbent layer, and then attaching this assembly of the conduit and the absorbent layer to the enclosing layer.
SPECIFIC DESCRIPTION OF THE PREFERRED EMBODIMENTS
Embodiments of the invention will now be described, by way of example, with reference to the accompanying drawings in which: Figure 1 is a view of the bottom side of a hyperbaric dressing according to an embodiment of the invention.
Figure 2 is a view of the top side of the hyperbaric dressing shown in Figure 1.
Figure 3 is a partial transverse section, on B-B of the dressing shown in Figure 1.
Figure 4 is a partial transverse section on C-C of the dressing shown in Figure 1.
Figure 5 is a view of the bottom side of a hyperbaric dressing according to another embodiment of the invention.
Figure 6 is a partial transverse section on D-D of the dressing shown in Figure 5.
io Figure 7 is a partial transverse section on E-E of the dressing shown in Figure 5.
Figure 8 is a side view of a dressing according to another embodiment of the invention.
Figure 9 is a side view of a dressing according to yet another embodiment of the invention.
Figure lOis a view of the bottom side of a hyperbaric dressing according to an embodiment of the invention.
A hyperbaric dressing 2, as shown in Figures 1, 2, 3 and 4 has an enclosing layer 4 impermeable to a first fluid, namely wound exudate, for forming an enclosure 5 around damaged tissue 7. The enclosing layer comprises a plastics material, polyurethane which is translucent or transparent. The enclosing layer also has an adhesive surface 14 on the side which faces the wound site 7. The adhesive surface is able to adhere to the skin 3 surrounding the wound to create a seal 9. The adhesive surface is exposed by peeling off a cover layer (not shown).
The hyperbaric dressing 2 also has an absorbent layer 6, comprising open-cell foam, which is contactable with the wound 7. It is absorbent to wound exudate.
The surface area of the enclosing layer 4 is greater than that of the absorbent layer 6 and the absorbent layer is positioned centrally with respect to the enclosing layer such that an island' of absorbent layer is created.
Consequently, in use, the absorbent layer is situated within the enclosure 5, as shown in Figure 3. A cavity in the form of a blind-ended slot 10 is defined within the absorbent layer. The slot extends through the entire thickness or depth of the absorbent layer. There is also an opening 12 through the absorbent layer at the blind end of the cavity. The opening is situated centrally within the absorbent layer and creates a window which is covered by the enclosing layer.
In this embodiment, the absorbent layer has a surface area of approximately 100cm2 contactable with the wound and a thickness of approximately 3 mm.
The opening 12 is circular and has a diameter of approximately 8 mm and the 0 cavity 10 is a slot approximately 2 mm wide.
The hyperbaric dressing also comprises a fluid conduit 8 which is an open-S ended tube. The tube is capable of delivering a second fluid, in this instance a gas, oxygen, to the enclosure 5. The tube is positioned within the cavity 10 and adheres to the enclosing layer 4. The end or outlet of the tube Ills positioned at the opening 12 of the absorbent layer. The tube thus extends into the enclosure.
In use, the hyperbaric dressing is applied over the wound such that the absorbent layer 6 contacts the damaged tissue and the enclosing layer 4 adheres to the skin surrounding the wound to create a seal 9. Figure 3 displays the dressing once it has adhered to the skin 3 surrounding the wound 7. The creation of a seal around the wound allows the enclosure 5 to form. Oxygen is supplied to the enclosure through the tube 8. The oxygen source is not shown.
The tube is spaced from the wound surface, as shown in Figures 3 and 4, by its adhesion to the adhesive surface 14 of the enclosing layer, advantageously avoiding the problems associated with directly contacting the tube with the wound such as the possibility of oxygen embolism and disturbance of granulation of new tissue when removed. The opening 12 allows the tube outlet 11 free space such that oxygen may be delivered directly to the wound surface. In addition, the characteristics of the wound may be observed through the window created by the opening. Advantageously, the positioning of the tube end 11 at the opening 12 may allow the observance of bubbling as the oxygen is delivered, thus acting as a visual cue to efficacy of the dressing. The oxygen is delivered a rate of approximately 12-15 mI/hour which is enough to overcome the breathability of the enclosing layer and obtain a pressure of approximately mm Hg within the enclosure or headspace 5. The open cell foam of the absorbent layer 6 has an absorption capacity of approximately 0.64m1/cm2. As the absorbent island has an area of approximately 100 cm2, the island is intended to absorb and retain approximately 64 ml of exudate. Thus high levels of exudate may be wicked away from the wound surface whilst retaining the ability to deliver oxygen to the wound site.
The dressing of this embodiment can conveniently be manufactured as follows.
The enclosing layer is provided as a large sheet, with an adhesive surface on one side. A portion of the sheet is cut out to provide the enclosing layer 4 of the dressing. The absorbent layer is also provided as a large sheet, and a portion of the sheet is cut out to provide the absorbent layer 6 of the dressing.
The absorbent layer is cut by a stamping operation using a shaped cutter. The cutter is shaped to cut not only the outer edge of the absorbent layer but also the cavity and the opening. As the cavity and the opening extend through the thickness of the absorbent layer, they can be cut in the same operation as cutting the outer edge of the absorbent layer.
The absorbent layer and the conduit may then be stuck to the adhesive surface of the enclosing layer in order to form the dressing.
Figures 5, 6 and 7 show another embodiment of a hyperbaric dressing.
Features similar to those shown in Figures 1 to 4 have been given like reference numerals. The hyperbaric dressing in Figures 5, 6 and 7 is substantially similar to that described for the embodiment shown in Figures 1 to 4 except that the cavity 10 in the absorbent layer 6 does not span the entire thickness of the absorbent layer. This creates a step or depression in the upper surface of the absorbent layer, distant from the wound, on which the conduit tube may rest. The thickness of this step helps to space the tube from the wound site 7. The tube also adheres to the adhesive surface 14 of the enclosing layer 4 to secure the tube in place. The opening 12 extends through the full thickness of the absorbent layer and is centrally positioned but is square shaped rather than circle shaped.
Figure 8 shows another embodiment of a hyperbaric dressing. Features similar to those shown in Figures 1 to 7 have been given like reference numerals. The hyperbaric dressing 2 does not possess a cavity in which the conduit 8 resides.
Instead, the tube merely rests on top of the absorbent layer 6, sandwiched between the absorbent layer and the enclosing layer 4. The tube is separated from the wound by the full thickness of the absorbent layer.
Figure 9 shows another embodiment of a hyperbaric dressing. Features similar to those shown in Figures 1 to 8 have been given like reference numerals. The io hyperbaric dressing 2 does not possess an opening through the absorbent layer 6. However, the absorbent layer 6 does define a cavity 10 in which the conduit tube 8 resides. The cavity 10 is a blind-ended tunnel completely enclosed within the absorbent layer and opening at an edge of the layer. In use the tube delivers oxygen to the enclosure. Oxygen diffuses from the tube end is 11 into the absorbent layer 6 which is open cell foam and so gas-permeable.
The gas can therefore diffuse to the wound site 7. The tube is separated from the wound site entirely by absorbent material and not by adhesion to the enclosing layer. The tube is able to adhere to the enclosing layer 4 where it emerges from the edge of the absorbent layer.
Figure 10 shows yet another embodiment of a hyperbaric dressing. Features similar to those shown in Figures 1 to 9 have been given like reference numerals. A plurality of openings 12 are defined through the thickness of the absorbent layer 6. Two of the openings are not associated with conduits 8, and are merely present as windows to enable the wound surface to be observed.
The four openings allow a greater proportion of the wound surface 7 to be observed. Conduit or tube ends 11 are positioned in the remaining two openings. Each tube 8 is positioned within a cavity 10, which is continuous with the respective opening 12. As with the embodiment shown in Figures ito 4, the cavity spans the entire thickness or depth of the absorbent layer and each tube is spaced from the wound surface 7 by its adhesion to the adhesive surface 14 of the enclosing layer 4.
Claims (23)
- Claims 1. A hyperbaric dressing comprising: an enclosing layer impermeable to a first fluid, for forming an enclosure around damaged tissue; an absorbent layer contactable with the damaged tissue, absorbent to a first fluid and arranged such that in use it is situated within the enclosure; and a fluid conduit for delivery of a second fluid to the enclosure, in which the fluid conduit is arranged such that it extends into the enclosure and is spaced from the damaged tissue.
- 2. A dressing according to claim 1, in which a cavity is defined within the absorbent layer, in which the fluid conduit is received.
- 3. A dressing according to any preceding claim, in which the fluid conduit is held away from the damaged tissue by a portion of the absorbent layer.
- 4. A dressing according to claim 1, 2 or 3, in which the enclosing layer further comprises an adhesive surface.
- 5. A dressing according to claim 4, in which the fluid conduit is held away from the damaged tissue by adhering to the adhesive surface.
- 6. A dressing according to any preceding claim, which comprises an opening through the absorbent layer.
- 7. A dressing according to claim 6, in which the opening is located in a substantially central position of the dressing.
- 8. A dressing according to claim 6 or claim 7, in which an end of the fluid conduit is positioned at the opening.-13 -
- 9. A dressing according to any preceding claim, in which the enclosing layer is gas permeable.
- 10. A dressing according to any preceding claim, in which the enclosing layer comprises transparent or translucent material.
- 11. A dressing according to any preceding claim, in which the absorbent layer comprises open-cell foam. l0
- 12. A dressing according to any preceding claim, in which the absorbent layer comprises material with an absorption capacity greater than or equal S to 0.1, 0.2, 0.3, 0.4, 0.5 or 0.6 mI/cm2.is
- 13. A dressing according to any preceding claim, in which the second fluid comprises oxygen.
- 14. A dressing according to claim 13, in which the fluid comprising oxygen is deliverable at a rate of 5 to 25, 10 to 20 or 12 to 15 mI/hour.
- 15. A method for manufacturing a hyperbaric dressing comprising the steps of: forming a cavity in an absorbent layer, absorbent to a first fluid; attaching a first surface of the absorbent layer to an enclosing layer; and inserting a portion of a fluid conduit, capable of delivering a second fluid, into the cavity such that it is spaced beneath a second surface of the absorbent layer distant from the enclosing layer.
- 16. A method according to claim 15, in which the enclosing layer is attached to the absorbent layer by adhesion.
- 17. A method according to claims 15 or 16, in which the fluid conduit is attached to the enclosing layer by adhesion.
- 18. A method according to claim 16 or 17, in which the enclosing layer has an adhesive surface for, in use, securing the dressing to the skin of a patient, and the same adhesive surface is used for adhesion ofthe absorbent layer and/or the conduit to the enclosing layer.
- 19. A method according to any of claims 15 to 18 which further comprises cutting an opening through the absorbent layer.io
- 20. A method according to claim 19, in which the opening is cut such that it is continuous with the cavity.
- 21. A method of treating a human or animal to assist the healing of damaged tissue, comprising the steps of: applying a hyperbaric dressing according to any of claims I to 14 to the damaged tissue; and supplying the dressing with the second fluid.
- 22. A dressing substantially as hereinbefore described with reference to the accompanying drawings.
- 23. A method for manufacturing a hyperbaric dressing substantially as described herein.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0908507.7A GB2470358B (en) | 2009-05-18 | 2009-05-18 | Hyperbaric dressing and method |
PCT/GB2010/000979 WO2010139926A1 (en) | 2009-05-18 | 2010-05-18 | Hyperbaric dressing and method of manufacturing |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0908507.7A GB2470358B (en) | 2009-05-18 | 2009-05-18 | Hyperbaric dressing and method |
Publications (3)
Publication Number | Publication Date |
---|---|
GB0908507D0 GB0908507D0 (en) | 2009-06-24 |
GB2470358A true GB2470358A (en) | 2010-11-24 |
GB2470358B GB2470358B (en) | 2014-05-14 |
Family
ID=40834157
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB0908507.7A Active GB2470358B (en) | 2009-05-18 | 2009-05-18 | Hyperbaric dressing and method |
Country Status (2)
Country | Link |
---|---|
GB (1) | GB2470358B (en) |
WO (1) | WO2010139926A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013156779A1 (en) * | 2012-04-19 | 2013-10-24 | Inotec Amd Limited | Oxygen distributor |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2619929A1 (en) | 2005-09-06 | 2007-03-15 | Tyco Healthcare Group Lp | Self contained wound dressing with micropump |
CA2964674A1 (en) | 2006-09-28 | 2008-03-28 | Smith & Nephew, Inc. | Portable wound therapy system |
GB0722820D0 (en) | 2007-11-21 | 2008-01-02 | Smith & Nephew | Vacuum assisted wound dressing |
US9061095B2 (en) | 2010-04-27 | 2015-06-23 | Smith & Nephew Plc | Wound dressing and method of use |
RU2615075C2 (en) | 2011-07-14 | 2017-04-03 | СМИТ ЭНД НЕФЬЮ ПиЭлСи | Wound dressing and methods |
CN107260399B (en) | 2012-03-12 | 2022-02-22 | 史密夫及内修公开有限公司 | Wound dressing apparatus for reduced pressure wound therapy |
US9427505B2 (en) | 2012-05-15 | 2016-08-30 | Smith & Nephew Plc | Negative pressure wound therapy apparatus |
RU2014151468A (en) | 2012-05-23 | 2016-07-20 | СМИТ ЭНД НЕФЬЮ ПиЭлСи | DEVICES AND METHODS OF TREATING RAS WITH APPLICATION OF NEGATIVE PRESSURE |
CN104884008B (en) | 2012-08-01 | 2020-02-28 | 史密夫及内修公开有限公司 | Wound dressing |
US10076449B2 (en) | 2012-08-01 | 2018-09-18 | Smith & Nephew Plc | Wound dressing and method of treatment |
CA2900771C (en) * | 2013-02-12 | 2020-02-18 | Electrochemical Oxygen Concepts, Inc. | Dressing for wound treatment |
US10610414B2 (en) | 2014-06-18 | 2020-04-07 | Smith & Nephew Plc | Wound dressing and method of treatment |
SG11201704254XA (en) | 2014-12-22 | 2017-07-28 | Smith & Nephew | Negative pressure wound therapy apparatus and methods |
GB2555584B (en) | 2016-10-28 | 2020-05-27 | Smith & Nephew | Multi-layered wound dressing and method of manufacture |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994021323A1 (en) * | 1993-03-23 | 1994-09-29 | Supra Medical Corporation | Topical hyperbaric device |
US20020150720A1 (en) * | 2001-04-16 | 2002-10-17 | Howard Pamela A. | Wound dressing system |
US20030212357A1 (en) * | 2002-05-10 | 2003-11-13 | Pace Edgar Alan | Method and apparatus for treating wounds with oxygen and reduced pressure |
GB2409412A (en) * | 2003-12-22 | 2005-06-29 | Johnson & Johnson Medical Ltd | Hyperbaric wound treatment device |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4624656A (en) * | 1983-07-25 | 1986-11-25 | Hospitak, Inc. | Hyperbaric gas treatment device |
US4969881A (en) * | 1989-11-06 | 1990-11-13 | Connecticut Artcraft Corp. | Disposable hyperbaric oxygen dressing |
FR2656218A1 (en) * | 1989-12-21 | 1991-06-28 | France Prod Oxygenes Co | Device for local treatment of the human or animal body using gas |
US5964723A (en) * | 1992-06-19 | 1999-10-12 | Augustine Medical, Inc. | Normothermic tissue heating wound covering |
US8287506B2 (en) * | 2007-10-26 | 2012-10-16 | Electrochemical Oxygen Concepts, Inc. | Apparatus and methods for controlling tissue oxygenation for wound healing and promoting tissue viability |
-
2009
- 2009-05-18 GB GB0908507.7A patent/GB2470358B/en active Active
-
2010
- 2010-05-18 WO PCT/GB2010/000979 patent/WO2010139926A1/en active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994021323A1 (en) * | 1993-03-23 | 1994-09-29 | Supra Medical Corporation | Topical hyperbaric device |
US20020150720A1 (en) * | 2001-04-16 | 2002-10-17 | Howard Pamela A. | Wound dressing system |
US20030212357A1 (en) * | 2002-05-10 | 2003-11-13 | Pace Edgar Alan | Method and apparatus for treating wounds with oxygen and reduced pressure |
GB2409412A (en) * | 2003-12-22 | 2005-06-29 | Johnson & Johnson Medical Ltd | Hyperbaric wound treatment device |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013156779A1 (en) * | 2012-04-19 | 2013-10-24 | Inotec Amd Limited | Oxygen distributor |
CN104519942A (en) * | 2012-04-19 | 2015-04-15 | 依诺泰克Amd有限公司 | Oxygen distributor |
US10080850B2 (en) | 2012-04-19 | 2018-09-25 | Inotec Amd Limited | Oxygen distributor |
US11179274B2 (en) * | 2012-04-19 | 2021-11-23 | Inotec Amd Limited | Oxygen distributor |
Also Published As
Publication number | Publication date |
---|---|
WO2010139926A1 (en) | 2010-12-09 |
GB0908507D0 (en) | 2009-06-24 |
GB2470358B (en) | 2014-05-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2470358A (en) | Hyperbaric dressing | |
US20120046603A1 (en) | Hyperbaric dressing and method | |
US11596555B2 (en) | Wound dressing for combined negative pressure and fluid delivery system | |
JP5634542B2 (en) | Negative pressure trauma treatment device | |
JP4213591B2 (en) | Pharmaceutical material for wound | |
EP2073771B1 (en) | A wound dressing | |
ES2236306T3 (en) | ADAPTABLE ACCESSORIES. | |
CN106390213A (en) | Multifunctional silica gel negative-pressure drainage device and manufacturing method thereof | |
US20060189909A1 (en) | Load relieving wound dressing | |
JPH07231909A (en) | Treating article for external fixation | |
JP2011521708A5 (en) | ||
US20050147654A1 (en) | Method and device for topical delivery of therapeutic agents to the skin | |
McCord et al. | Practical guide to pediatric wound care | |
Psoinos et al. | Use of gauze-based negative pressure wound therapy in a pediatric burn patient | |
CN215229233U (en) | Hydrophilic dressing capable of absorbing seepage | |
KR100901315B1 (en) | The moist wound dressing and a medical treatment method using a laser beam | |
CN211409709U (en) | Hydrogel wound dressing | |
US20200345992A1 (en) | Hydrogen-enhanced transdermal system | |
Wongkietkachorn et al. | Periwound challenges improve patient satisfaction in wound care | |
CN201389127Y (en) | Carbon fiber plaster application | |
CN216535780U (en) | Anti-sensitive dressing patch with good sealing performance | |
CN214967730U (en) | Abdominal wound healing device | |
CN215273862U (en) | Silica gel healing patch | |
CN211934532U (en) | Sterile wound plaster | |
CN207871058U (en) | A kind of adhesive bandage being pasted with biological hemostatic film |